{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:04:33Z","timestamp":1794269073197,"version":"4.9.0"},"reference-count":204,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH124671"],"award-info":[{"award-number":["MH124671"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH062646"],"award-info":[{"award-number":["MH062646"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","award":["T32 GM149363"],"award-info":[{"award-number":["T32 GM149363"]}],"id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014387","name":"ACADIA Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014387","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS031373"],"award-info":[{"award-number":["NS031373"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["NS132060"],"award-info":[{"award-number":["NS132060"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.neuropharm.2024.109897","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T16:09:11Z","timestamp":1709914151000},"page":"109897","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Novel pharmacological targets for GABAergic dysfunction in ADHD"],"prefix":"10.1016","volume":"249","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4882-2049","authenticated-orcid":false,"given":"Anthony S.","family":"Ferranti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah J.","family":"Luessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen M.","family":"Niswender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.neuropharm.2024.109897_bib1","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/mgg3.230","article-title":"ADGRL3 (LPHN3) variants are associated with a refined phenotype of ADHD in the MTA study","volume":"4","author":"Acosta","year":"2016","journal-title":"Molecular Genetics & Genomic Medicine"},{"issue":"5","key":"10.1016\/j.neuropharm.2024.109897_bib2","doi-asserted-by":"crossref","first-page":"e1137","DOI":"10.1038\/tp.2017.104","article-title":"Shifting brain inhibitory balance and connectivity of the prefrontal cortex of adults with autism spectrum disorder","volume":"7","author":"Ajram","year":"2017","journal-title":"Transl. Psychiatry"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.109897_bib3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1017\/S1740925X11000093","article-title":"Roles of glutamine in neurotransmission","volume":"6","author":"Albrecht","year":"2010","journal-title":"Neuron Glia Biol."},{"issue":"Pt 1","key":"10.1016\/j.neuropharm.2024.109897_bib4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1469-7793.1998.201bu.x","article-title":"CA1 pyramidal to basket and bistratified cell EPSPs: dual intracellular recordings in rat hippocampal slices","volume":"507","author":"Ali","year":"1998","journal-title":"J. Physiol."},{"issue":"Pt 1","key":"10.1016\/j.neuropharm.2024.109897_bib5","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1469-7793.1998.185bu.x","article-title":"Facilitating pyramid to horizontal oriens-alveus interneurone inputs: dual intracellular recordings in slices of rat hippocampus","volume":"507","author":"Ali","year":"1998","journal-title":"J. Physiol."},{"issue":"16","key":"10.1016\/j.neuropharm.2024.109897_bib6","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.jpsychires.2010.04.026","article-title":"Reduced right frontal cortical thickness in children, adolescents and adults with ADHD and its correlation to clinical variables: a cross-sectional study","volume":"44","author":"Almeida","year":"2010","journal-title":"J. Psychiatr. Res."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.109897_bib7","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1177\/1087054711434351","article-title":"Brain cortical thickness in ADHD: age, sex, and clinical correlations","volume":"17","author":"Almeida Montes","year":"2013","journal-title":"J. Atten. Disord."},{"key":"10.1016\/j.neuropharm.2024.109897_bib8","article-title":"Alleviation of ADHD symptoms by non-invasive right prefrontal stimulation is correlated with EEG activity","volume":"26","author":"Alyagon","year":"2020","journal-title":"Neuroimage : Clinical"},{"issue":"11","key":"10.1016\/j.neuropharm.2024.109897_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/mp.2010.6","article-title":"A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication","volume":"15","author":"Arcos-Burgos","year":"2010","journal-title":"Mol. Psychiatr."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109897_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-019-0396-7","article-title":"ADGRL3 (LPHN3) variants predict substance use disorder","volume":"9","author":"Arcos-Burgos","year":"2019","journal-title":"Transl. Psychiatry"},{"issue":"8","key":"10.1016\/j.neuropharm.2024.109897_bib11","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1601-183X.2011.00724.x","article-title":"CDH13 is associated with working memory performance in attention deficit\/hyperactivity disorder","volume":"10","author":"Arias-V\u00e1squez","year":"2011","journal-title":"Gene Brain Behav."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.109897_bib12","doi-asserted-by":"crossref","first-page":"I","DOI":"10.1016\/j.jpeds.2009.01.018","article-title":"The emerging neurobiology of attention deficit hyperactivity disorder: the key role of the prefrontal association cortex","volume":"154","author":"Arnsten","year":"2009","journal-title":"J. Pediatr."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109897_bib13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.pbb.2011.01.020","article-title":"Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit hyperactivity disorder and related disorders","volume":"99","author":"Arnsten","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.109897_bib14","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.neuropharm.2007.12.009","article-title":"Group III mGluR regulation of synaptic transmission at the SC-CA1 synapse is developmentally regulated","volume":"54","author":"Ayala","year":"2008","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.109897_bib15","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1471-4159.2006.03913.x","article-title":"The glutamate\/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer","volume":"98","author":"Bak","year":"2006","journal-title":"J. Neurochem."},{"issue":"5\u20136","key":"10.1016\/j.neuropharm.2024.109897_bib16","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/1438-826X(200012)1:5\/6<194::AID-GNFD194>3.0.CO;2-2","article-title":"Identification of polymorphisms in the GABAB receptor gene and linkage study of attention-deficit hyperactivity disorder","volume":"1","author":"Barr","year":"2000","journal-title":"Gene Funct. Dis."},{"key":"10.1016\/j.neuropharm.2024.109897_bib17","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1113\/jphysiol.1991.sp018901","article-title":"Agonists at metabotropic glutamate receptors presynaptically inhibit EPSCs in neonatal rat hippocampus","volume":"444","author":"Baskys","year":"1991","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2024.109897_bib18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neuroimage.2018.09.016","article-title":"Inhibitory and excitatory mechanisms in the human cingulate-cortex support reinforcement learning: a functional Proton Magnetic Resonance Spectroscopy study","volume":"184","author":"Bezalel","year":"2019","journal-title":"Neuroimage"},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109897_bib19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1348\/026151008X314919","article-title":"Assessing inattention and impulsivity in children during the Go\/NoGo task","volume":"27","author":"Bezdjian","year":"2009","journal-title":"Br. J. Dev. Psychol."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.109897_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.79","article-title":"Developmental changes in gamma-aminobutyric acid levels in attention-deficit\/hyperactivity disorder","volume":"5","author":"Bollmann","year":"2015","journal-title":"Transl. Psychiatry"},{"issue":"7","key":"10.1016\/j.neuropharm.2024.109897_bib21","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1177\/1087054715619682","article-title":"Regional gray matter volume differences between adolescents with ADHD and typically developing controls: further evidence for anterior cingulate involvement","volume":"22","author":"Bonath","year":"2018","journal-title":"J. Atten. Disord."},{"issue":"7","key":"10.1016\/j.neuropharm.2024.109897_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/mp.2016.74","article-title":"Attention-deficit hyperactivity disorder in adults: a systematic review and meta-analysis of genetic, pharmacogenetic and biochemical studies","volume":"21","author":"Bonvicini","year":"2016","journal-title":"Mol. Psychiatr."},{"issue":"9","key":"10.1016\/j.neuropharm.2024.109897_bib23","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.biopsych.2011.05.030","article-title":"Dorso-lateral prefrontal \u03b3-amino butyric acid in men predicts individual differences in rash impulsivity","volume":"70","author":"Boy","year":"2011","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2024.109897_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2022.108982","article-title":"The comparative effects of mGlu5 receptor positive allosteric modulators VU0409551 and VU0360172 on cognitive deficits and signalling in the sub-chronic PCP rat model for schizophrenia","volume":"208","author":"Brown","year":"2022","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.neuropharm.2024.109897_bib25","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/ajmg.b.32489","article-title":"GAD1 gene polymorphisms are associated with hyperactivity in Attention-Deficit\/Hyperactivity Disorder","volume":"171","author":"Bruxel","year":"2016","journal-title":"Am. J. Med. Genet. Part B: Neuropsychiatric Genetics"},{"issue":"11","key":"10.1016\/j.neuropharm.2024.109897_bib26","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.biopsych.2005.01.034","article-title":"Functional neuroimaging of attention-deficit\/hyperactivity disorder: a review and suggested future directions","volume":"57","author":"Bush","year":"2005","journal-title":"Biol. Psychiatr."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109897_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-022-02182-8","article-title":"Comprehensive analysis of omics data identifies relevant gene networks for Attention-Deficit\/Hyperactivity Disorder (ADHD)","volume":"12","author":"Cabana-Dom\u00ednguez","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2024.109897_bib28","article-title":"Bayesian dynamical system analysis of the effects of methylphenidate in children with attention-deficit\/hyperactivity disorder: a randomized trial","volume":"1\u20139","author":"Cai","year":"2023","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109897_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/cap.2006.0008","article-title":"Striatal creatine and glutamate\/glutamine in attention-deficit\/hyperactivity disorder","volume":"17","author":"Carrey","year":"2007","journal-title":"J. Child Adolesc. Psychopharmacol."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109897_bib30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.tics.2011.11.007","article-title":"Large-scale brain systems in ADHD: beyond the prefrontal-striatal model","volume":"16","author":"Castellanos","year":"2012","journal-title":"Trends Cognit. Sci."},{"key":"10.1016\/j.neuropharm.2024.109897_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2022.114145","article-title":"Effects of transcranial direct current stimulation on improving performance of delayed- reinforcement attentional set-shifting tasks in attention-deficit\/hyperactivity disorder rat model","volume":"437","author":"Chen","year":"2023","journal-title":"Behav. Brain Res."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.109897_bib32","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.neuron.2015.02.019","article-title":"Gamma rhythms link prefrontal interneuron dysfunction with cognitive inflexibility in Dlx5\/6+\/\u2212 mice","volume":"85","author":"Cho","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2024.109897_bib33","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41398-019-0580-9","article-title":"Lrrc7 mutant mice model developmental emotional dysregulation that can be alleviated by mGluR5 allosteric modulation","volume":"9","author":"Chong","year":"2019","journal-title":"Transl. Psychiatry"},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109897_bib34","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0167-8760(02)00119-8","article-title":"Effects of stimulant medications on the EEG of children with attention-deficit\/hyperactivity disorder predominantly inattentive type","volume":"47","author":"Clarke","year":"2003","journal-title":"Int. J. Psychophysiol."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109897_bib35","article-title":"Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders","volume":"8","author":"Conn","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.109897_bib36","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1177\/2168479015599811","article-title":"ADHD & pharmacotherapy: past, present and future","volume":"49","author":"Connolly","year":"2015","journal-title":"Therapeutic Innov. & Regulatory Sci."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.109897_bib37","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jaac.2014.12.010","article-title":"Cognitive training for attention-deficit\/hyperactivity disorder: meta-analysis of clinical and neuropsychological outcomes from randomized controlled trials","volume":"54","author":"Cortese","year":"2015","journal-title":"J. Am. Acad. Child Adolesc. Psychiatr."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109897_bib38","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1176\/jnp.16.1.63","article-title":"Neurometabolic functioning and neuropsychological correlates in children with ADHD-H: preliminary findings","volume":"16","author":"Courvoisie","year":"2004","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109897_bib40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ydbio.2018.03.023","article-title":"The role of ADHD associated genes in neurodevelopment","volume":"438","author":"Dark","year":"2018","journal-title":"Dev. Biol."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109897_bib41","doi-asserted-by":"crossref","DOI":"10.1038\/s41588-022-01285-8","article-title":"Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains","volume":"55","author":"Demontis","year":"2023","journal-title":"Nat. Genet."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109897_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41588-018-0269-7","article-title":"Discovery of the first genome-wide significant risk loci for attention deficit\/hyperactivity disorder","volume":"51","author":"Demontis","year":"2019","journal-title":"Nat. Genet."},{"issue":"11","key":"10.1016\/j.neuropharm.2024.109897_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080491","article-title":"Mutation of Elfn1 in mice causes seizures and hyperactivity","volume":"8","author":"Dolan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2024.109897_bib44","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jpsychires.2021.02.050","article-title":"High-gamma oscillations as neurocorrelates of ADHD: a MEG crossover placebo-controlled study","volume":"137","author":"Dor-Ziderman","year":"2021","journal-title":"J. Psychiatr. Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109897_bib45","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1096\/fj.10-163147","article-title":"A new approach to analyze cell surface protein complexes reveals specific heterodimeric metabotropic glutamate receptors","volume":"25","author":"Doumazane","year":"2011","journal-title":"Faseb. J.: Off. Publ. Fed. Am. Soc. Experimental Biol."},{"issue":"7864","key":"10.1016\/j.neuropharm.2024.109897_bib46","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41586-021-03641-w","article-title":"Structures of human mGlu2 and mGlu7 homo- and heterodimers","volume":"594","author":"Du","year":"2021","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.neuropharm.2024.109897_bib47","doi-asserted-by":"crossref","first-page":"5022","DOI":"10.1073\/pnas.1722498115","article-title":"Synaptic adhesion protein ELFN1 is a selective allosteric modulator of group III metabotropic glutamate receptors in trans","volume":"115","author":"Dunn","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.neuropharm.2024.109897_bib48","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1038\/s41380-019-0512-3","article-title":"ELFN2 is a postsynaptic cell adhesion molecule with essential roles in controlling group III mGluRs in the brain and neuropsychiatric behavior","volume":"24","author":"Dunn","year":"2019","journal-title":"Mol. Psychiatr."},{"issue":"7","key":"10.1016\/j.neuropharm.2024.109897_bib49","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/archgenpsychiatry.2011.2280","article-title":"Reduced GABA concentration in attention-deficit\/hyperactivity disorder","volume":"69","author":"Edden","year":"2012","journal-title":"Arch. Gen. Psychiatr."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.109897_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/mp.2009.57","article-title":"Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes","volume":"15","author":"Elia","year":"2010","journal-title":"Mol. Psychiatr."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109897_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/ng.1013","article-title":"Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder","volume":"44","author":"Elia","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2024.109897_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2017.00976","article-title":"Differences in executive functioning in children with attention deficit and hyperactivity disorder (ADHD)","volume":"8","author":"Elos\u00faa","year":"2017","journal-title":"Front. Psychol."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109897_bib53","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/npp.2015.153","article-title":"Impulsivity and aggression in female BPD and ADHD patients: association with ACC glutamate and GABA concentrations","volume":"41","author":"Ende","year":"2016","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.neuropharm.2024.109897_bib54","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.3390\/ijms24065270","article-title":"Epilepsy and attention deficit hyperactivity disorder: connection, chance, and challenges","volume":"24","author":"Fan","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.109897_bib55","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1162\/089892902317361886","article-title":"Testing the efficiency and independence of attentional networks","volume":"14","author":"Fan","year":"2002","journal-title":"J. Cognit. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109897_bib56","article-title":"Attention-deficit\/hyperactivity disorder","volume":"1","author":"Faraone","year":"2015","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.neuropharm.2024.109897_bib57","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.neubiorev.2021.01.022","article-title":"The world federation of ADHD international consensus statement: 208 evidence-based conclusions about the disorder","volume":"128","author":"Faraone","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109897_bib58","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.schres.2010.12.025","article-title":"Deficits in GABAB receptor system in schizophrenia and mood disorders: a postmortem study","volume":"128","author":"Fatemi","year":"2011","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109897_bib59","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10803-008-0646-7","article-title":"GABAA receptor downregulation in brains of subjects with autism","volume":"39","author":"Fatemi","year":"2009","journal-title":"J. Autism Dev. Disord."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.109897_bib60","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.biopsych.2017.11.033","article-title":"Thalamic control of cognition and social behavior via regulation of GABAergic signaling and E\/I balance in the medial prefrontal cortex","volume":"83","author":"Ferguson","year":"2018","journal-title":"Biol. Psychiatr."},{"issue":"34","key":"10.1016\/j.neuropharm.2024.109897_bib61","doi-asserted-by":"crossref","first-page":"12941","DOI":"10.1073\/pnas.0605493103","article-title":"Distinct roles of the anterior cingulate and prefrontal cortex in the acquisition and performance of a cognitive skill","volume":"103","author":"Fincham","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.neuropharm.2024.109897_bib62","doi-asserted-by":"crossref","DOI":"10.1111\/gbb.12654","article-title":"Phenotypic profiling of mGlu7 knockout mice reveals new implications for neurodevelopmental disorders","volume":"19","author":"Fisher","year":"2020","journal-title":"Gene Brain Behav."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.109897_bib63","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.neuron.2017.03.016","article-title":"Allosteric modulation of GPCRs: new insights and potential utility for treatment of schizophrenia and other CNS disorders","volume":"94","author":"Foster","year":"2017","journal-title":"Neuron"},{"issue":"10","key":"10.1016\/j.neuropharm.2024.109897_bib64","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.euroneuro.2018.08.001","article-title":"Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan","volume":"28","author":"Franke","year":"2018","journal-title":"Eur. Neuropsychopharmacol"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109897_bib65","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.bbr.2012.03.017","article-title":"GABA system changes in methylphenidate sensitized female rats","volume":"231","author":"Freese","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2024.109897_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2023.173546","article-title":"GRM7 gene mutations and consequences for neurodevelopment","volume":"225","author":"Freitas","year":"2023","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2024.109897_bib67","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3389\/neuro.02.005.2008","article-title":"Epilepsy, E\/I balance and GABAA receptor plasticity","volume":"1","author":"Fritschy","year":"2008","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.109897_bib68","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuroimage.2017.06.078","article-title":"Inferring synaptic excitation\/inhibition balance from field potentials","volume":"158","author":"Gao","year":"2017","journal-title":"Neuroimage"},{"issue":"10","key":"10.1016\/j.neuropharm.2024.109897_bib69","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1021\/acschemneuro.7b00167","article-title":"Role of mGlu5 receptors and inhibitory neurotransmission in M1 dependent muscarinic LTD in the prefrontal cortex: implications in schizophrenia","volume":"8","author":"Ghoshal","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.109897_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2022.119034","article-title":"EEG variability: task-driven or subject-driven signal of interest?","volume":"252","author":"Gibson","year":"2022","journal-title":"Neuroimage"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109897_bib71","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s11689-023-09483-z","article-title":"Rare recurrent copy number variations in metabotropic glutamate receptor interacting genes in children with neurodevelopmental disorders","volume":"15","author":"Glessner","year":"2023","journal-title":"J. Neurodev. Disord."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.109897_bib72","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s11920-010-0124-8","article-title":"Alterations of cortical GABA neurons and network oscillations in schizophrenia","volume":"12","author":"Gonzalez-Burgos","year":"2010","journal-title":"Curr. Psychiatr. Rep."},{"issue":"11","key":"10.1016\/j.neuropharm.2024.109897_bib73","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/archpsyc.57.11.1061","article-title":"Decrease in reelin and glutamic acid Decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study","volume":"57","author":"Guidotti","year":"2000","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2024.109897_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2021.110340","article-title":"Right prefrontal activation predicts ADHD and its severity: a TMS-EEG study in young adults","volume":"111","author":"Hadas","year":"2021","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.109897_bib75","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1017\/S1355617712000355","article-title":"Set-shifting in adults with ADHD","volume":"18","author":"Halleland","year":"2012","journal-title":"J. Int. Neuropsychol. Soc."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.109897_bib76","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.clinph.2021.01.023","article-title":"Relationship between GABA levels and task-dependent cortical excitability in children with attention-deficit\/hyperactivity disorder","volume":"132","author":"Harris","year":"2021","journal-title":"Clin. Neurophysiol. : Off. J. Int. Fed. Clin. Neurophysiol."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109897_bib77","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1001\/jamapsychiatry.2013.277","article-title":"Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit\/hyperactivity disorder: exploring task-specific, stimulant medication, and age effects","volume":"70","author":"Hart","year":"2013","journal-title":"JAMA Psychiatr."},{"issue":"11","key":"10.1016\/j.neuropharm.2024.109897_bib78","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1111\/ejn.12485","article-title":"Brain \u03b3-aminobutyric acid: a neglected role in impulsivity","volume":"39","author":"Hayes","year":"2014","journal-title":"Eur. J. Neurosci."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.109897_bib79","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1038\/s41380-019-0540-z","article-title":"Druggable genome in attention deficit\/hyperactivity disorder and its co-morbid conditions. New avenues for treatment","volume":"26","author":"Hegvik","year":"2021","journal-title":"Mol. Psychiatr."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.109897_bib80","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.neubiorev.2003.09.003","article-title":"The medial prefrontal cortex in the rat: evidence for a dorso-ventral distinction based upon functional and anatomical characteristics","volume":"27","author":"Heidbreder","year":"2003","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"36","key":"10.1016\/j.neuropharm.2024.109897_bib81","doi-asserted-by":"crossref","first-page":"7844","DOI":"10.1523\/JNEUROSCI.0760-18.2018","article-title":"Brain GABA levels are associated with inhibitory control deficits in older adults","volume":"38","author":"Hermans","year":"2018","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.109897_bib82","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.nbd.2013.11.012","article-title":"Focal epileptiform activity in the prefrontal cortex is associated with long-term attention and sociability deficits","volume":"63","author":"Hernan","year":"2014","journal-title":"Neurobiol. Dis."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.109897_bib83","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.tins.2020.03.007","article-title":"Where is cingulate cortex? A cross-species view","volume":"43","author":"Heukelum","year":"2020","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2024.109897_bib84","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fnana.2014.00050","article-title":"Spatio-temporal extension in site of origin for cortical calretinin neurons in primates","volume":"8","author":"Hladnik","year":"2014","journal-title":"Front. Neuroanat."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109897_bib85","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0022-3565(24)38151-0","article-title":"The regulation of dopamine transmission by metabotropic glutamate receptors","volume":"289","author":"Hu","year":"1999","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2024.109897_bib86","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.971349","article-title":"Defining the interconnectivity of the medial prefrontal cortex and ventral midbrain","volume":"15","author":"Hui","year":"2022","journal-title":"Front. Mol. Neurosci."},{"issue":"12","key":"10.1016\/j.neuropharm.2024.109897_bib88","article-title":"Neuroimaging-aided prediction of the effect of methylphenidate in children with attention-deficit hyperactivity disorder: a randomized controlled trial","volume":"40","author":"Ishii-Takahashi","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2024.109897_bib89","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.conb.2017.03.005","article-title":"Synaptic adhesion molecules and excitatory synaptic transmission","volume":"45","author":"Jang","year":"2017","journal-title":"Curr. Opin. Neurobiol."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109897_bib90","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-023-02541-z","article-title":"Control of sustained attention and impulsivity by Gq-protein signalling in parvalbumin interneurons of the anterior cingulate cortex","volume":"13","author":"Jendryka","year":"2023","journal-title":"Transl. Psychiatry"},{"issue":"6","key":"10.1016\/j.neuropharm.2024.109897_bib91","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.neuron.2021.12.027","article-title":"Acute restraint stress redirects prefrontal cortex circuit function through mGlu5 receptor plasticity on somatostatin-expressing interneurons","volume":"110","author":"Joffe","year":"2022","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2024.109897_bib92","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuropharm.2018.10.013","article-title":"Mechanisms underlying prelimbic prefrontal cortex mGlu3\/mGlu5-dependent plasticity and reversal learning deficits following acute stress","volume":"144","author":"Joffe","year":"2019","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109897_bib93","first-page":"169","article-title":"EEG power spectrum analysis in children with ADHD","volume":"59","author":"Kamida","year":"2016","journal-title":"Yonago Acta Med."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.109897_bib94","doi-asserted-by":"crossref","DOI":"10.1002\/dev.22228","article-title":"Electroencephalogram aperiodic power spectral slope can be reliably measured and predicts ADHD risk in early development","volume":"64","author":"Karalunas","year":"2022","journal-title":"Dev. Psychobiol."},{"issue":"11","key":"10.1016\/j.neuropharm.2024.109897_bib95","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.jpsychires.2012.07.017","article-title":"Increased gamma oscillations during voluntary selection processes in adult patients with attention deficit\/hyperactivity disorder","volume":"46","author":"Karch","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neuropharm.2024.109897_bib96","article-title":"Cortical interneurons: fit for function and fit to function? Evidence from development and evolution","volume":"17","author":"Keijser","year":"2023","journal-title":"Front. Neural Circ."},{"issue":"7483","key":"10.1016\/j.neuropharm.2024.109897_bib97","doi-asserted-by":"crossref","DOI":"10.1038\/nature12983","article-title":"Interneuron cell types are fit to function","volume":"505","author":"Kepecs","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2024.109897_bib98","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.925049","article-title":"Attention-deficit\/hyperactive disorder updates","volume":"15","author":"Kessi","year":"2022","journal-title":"Front. Mol. Neurosci."},{"issue":"19","key":"10.1016\/j.neuropharm.2024.109897_bib99","doi-asserted-by":"crossref","first-page":"7600","DOI":"10.1523\/JNEUROSCI.4543-14.2015","article-title":"Activation of metabotropic glutamate receptor 7 is required for induction of long-term potentiation at SC-CA1 synapses in the Hippocampus","volume":"35","author":"Klar","year":"2015","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109897_bib100","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00004583-200502000-00010","article-title":"Computerized training of working memory in children with ADHD-A randomized, controlled trial","volume":"44","author":"Klingberg","year":"2005","journal-title":"J. Am. Acad. Child Adolesc. Psychiatr."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.109897_bib101","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1076\/jcen.24.6.781.8395","article-title":"Training of working memory in children with ADHD","volume":"24","author":"Klingberg","year":"2002","journal-title":"J. Clin. Exp. Neuropsychol."},{"issue":"7","key":"10.1016\/j.neuropharm.2024.109897_bib102","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.biopsych.2005.08.013","article-title":"Dysfunctional attentional networks in children with attention deficit\/hyperactivity disorder: evidence from an event-related functional magnetic resonance imaging study","volume":"59","author":"Konrad","year":"2006","journal-title":"Biol. Psychiatr."},{"issue":"45","key":"10.1016\/j.neuropharm.2024.109897_bib103","doi-asserted-by":"crossref","first-page":"8468","DOI":"10.1523\/JNEUROSCI.1136-22.2022","article-title":"Prefrontal interneurons: populations, pathways, and plasticity supporting typical and disordered cognition in rodent models","volume":"42","author":"Kupferschmidt","year":"2022","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.neuropharm.2024.109897_bib104","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/ajmg.b.32083","article-title":"Refining psychiatric phenotypes for response to treatment: contribution of LPHN3 in ADHD","volume":"159B","author":"Labbe","year":"2012","journal-title":"Am. J. Med. Genet. Part B: Neuropsychiatric Genetics"},{"issue":"8","key":"10.1016\/j.neuropharm.2024.109897_bib105","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/ajmg.b.30867","article-title":"Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations","volume":"147B","author":"Lasky-Su","year":"2008","journal-title":"Am. J. Med. Genet. Part B: Neuropsychiatric Genetics"},{"issue":"5","key":"10.1016\/j.neuropharm.2024.109897_bib106","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0315-18.2018","article-title":"What, if anything, is rodent prefrontal cortex?","volume":"5","author":"Laubach","year":"2018","journal-title":"eNeuro"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109897_bib107","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.emc.2023.06.012","article-title":"Schizophrenia and emergency medicine","volume":"42","author":"Lawrence","year":"2024","journal-title":"Emerg. Med. Clin."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.109897_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107605","article-title":"Defining the homo- and heterodimerization propensities of metabotropic glutamate receptors","volume":"31","author":"Lee","year":"2020","journal-title":"Cell Rep."},{"issue":"50","key":"10.1016\/j.neuropharm.2024.109897_bib109","doi-asserted-by":"crossref","first-page":"16796","DOI":"10.1523\/JNEUROSCI.1869-10.2010","article-title":"The largest group of superficial neocortical GABAergic interneurons expresses ionotropic serotonin receptors","volume":"30","author":"Lee","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.109897_bib110","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.brainres.2008.06.023","article-title":"Enhanced gamma-band activity in ADHD patients lacks correlation with memory performance found in healthy children","volume":"1235","author":"Lenz","year":"2008","journal-title":"Brain Res."},{"issue":"11","key":"10.1016\/j.neuropharm.2024.109897_bib111","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s00702-008-0119-3","article-title":"Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies","volume":"115","author":"Lesch","year":"2008","journal-title":"J. Neural. Transm."},{"issue":"10","key":"10.1016\/j.neuropharm.2024.109897_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2022.102458","article-title":"Differential activity of mGlu7 allosteric modulators provides evidence for mGlu7\/8 heterodimers at hippocampal Schaffer collateral-CA1 synapses","volume":"298","author":"Lin","year":"2022","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.109897_bib113","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.braindev.2013.04.013","article-title":"Epilepsy associated with autism and attention deficit hyperactivity disorder: is there a genetic link?","volume":"36","author":"Lo-Castro","year":"2014","journal-title":"Brain Dev."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.109897_bib114","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s13311-012-0131-z","article-title":"Clinical utility of EEG in attention-deficit\/hyperactivity disorder: a research update","volume":"9","author":"Loo","year":"2012","journal-title":"Neurotherapeutics"},{"issue":"12","key":"10.1016\/j.neuropharm.2024.109897_bib115","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0006-3223(98)00250-9","article-title":"EEG correlates of methylphenidate response among children with ADHD: a preliminary report","volume":"45","author":"Loo","year":"1999","journal-title":"Biol. Psychiatr."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.109897_bib116","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1124\/pharmrev.121.000540","article-title":"Allosteric modulators of metabotropic glutamate receptors as novel therapeutics for neuropsychiatric disease","volume":"74","author":"Luessen","year":"2022","journal-title":"Pharmacol. Rev."},{"issue":"10","key":"10.1016\/j.neuropharm.2024.109897_bib117","doi-asserted-by":"crossref","DOI":"10.1038\/s41386-022-01350-0","article-title":"mGlu1-mediated restoration of prefrontal cortex inhibitory signaling reverses social and cognitive deficits in an NMDA hypofunction model in mice","volume":"47","author":"Luessen","year":"2022","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109897_bib118","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ejphar.2007.10.030","article-title":"Group III metabotropic glutamate receptors act as hetero-receptors modulating evoked GABA release in the globus pallidus in vivo","volume":"580","author":"MacInnes","year":"2008","journal-title":"Eur. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109897_bib119","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0006-3223(02)01401-4","article-title":"Proton spectroscopy in medication-free pediatric attention-deficit\/hyperactivity disorder","volume":"53","author":"MacMaster","year":"2003","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2024.109897_bib120","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.neuropharm.2018.05.034","article-title":"Amphetamine improves mouse and human attention in the 5-Choice Continuous Performance Task","volume":"138","author":"MacQueen","year":"2018","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.neuropharm.2024.109897_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109950","article-title":"mGlu1 potentiation enhances prelimbic somatostatin interneuron activity to rescue schizophrenia-like physiological and cognitive deficits","volume":"37","author":"Maksymetz","year":"2021","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.109897_bib122","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1038\/tp.2014.11","article-title":"Glutamate\/glutamine and neuronal integrity in adults with ADHD: a proton MRS study","volume":"4","author":"Maltezos","year":"2014","journal-title":"Transl. Psychiatry"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109897_bib123","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/brainsci11010091","article-title":"Precision medicine care in ADHD: the case for neural excitation and inhibition","volume":"11","author":"Mamiya","year":"2021","journal-title":"Brain Sci."},{"issue":"9","key":"10.1016\/j.neuropharm.2024.109897_bib124","doi-asserted-by":"crossref","first-page":"4677","DOI":"10.3390\/ijms23094677","article-title":"Reduced glx and GABA inductions in the anterior cingulate cortex and caudate nucleus are related to impaired control of attention in attention-deficit\/hyperactivity disorder","volume":"23","author":"Mamiya","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.neuropharm.2024.109897_bib125","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0014-2999(00)00633-6","article-title":"Activation of group III metabotropic glutamate receptors inhibits basal and amphetamine-stimulated dopamine release in rat dorsal striatum: an in vivo microdialysis study","volume":"404","author":"Mao","year":"2000","journal-title":"Eur. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.109897_bib126","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1038\/npp.2010.35","article-title":"Genetic modulation of GABA levels in the anterior cingulate cortex by GAD1 and COMT","volume":"35","author":"Marenco","year":"2010","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109897_bib127","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/1550059416643824","article-title":"Quantitative EEG in children and adults with attention deficit hyperactivity disorder: comparison of absolute and relative power spectra and theta\/beta ratio","volume":"48","author":"Markovska-Simoska","year":"2017","journal-title":"Clin. EEG Neurosci."},{"key":"10.1016\/j.neuropharm.2024.109897_bib128","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.neuropharm.2015.03.029","article-title":"Sex differences in GABABR-GIRK signaling in layer 5\/6 pyramidal neurons of the mouse prelimbic cortex","volume":"95","author":"Marron Fernandez de Velasco","year":"2015","journal-title":"Neuropharmacology"},{"issue":"11","key":"10.1016\/j.neuropharm.2024.109897_bib129","doi-asserted-by":"crossref","first-page":"e944","DOI":"10.1038\/tp.2016.218","article-title":"You say \u2018prefrontal cortex\u2019 and I say \u2018anterior cingulate\u2019: meta-analysis of spatial overlap in amygdala-to-prefrontal connectivity and internalizing symptomology","volume":"6","author":"Marusak","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2024.109897_bib130","article-title":"Trans-synaptic regulation of metabotropic glutamate receptors by Elfn proteins in health and disease","volume":"15","author":"Matsunaga","year":"2021","journal-title":"Front. Neural Circ."},{"issue":"9","key":"10.1016\/j.neuropharm.2024.109897_bib131","first-page":"4447","article-title":"Hippocampal neural disinhibition causes attentional and memory deficits","volume":"27","author":"McGarrity","year":"2017","journal-title":"Cerebr. Cortex"},{"issue":"8","key":"10.1016\/j.neuropharm.2024.109897_bib132","doi-asserted-by":"crossref","DOI":"10.1038\/s41589-022-01050-2","article-title":"Nanobody-based sensors reveal a high proportion of mGlu heterodimers in the brain","volume":"18","author":"Meng","year":"2022","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.neuropharm.2024.109897_bib133","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.neubiorev.2014.12.001","article-title":"Sensitive and critical periods during neurotypical and aberrant neurodevelopment: a framework for neurodevelopmental disorders","volume":"50","author":"Meredith","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2024.109897_bib134","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41398-022-02207-2","article-title":"Treatment biomarkers for ADHD: taking stock and moving forward","volume":"12","author":"Michelini","year":"2022","journal-title":"Transl. Psychiatry"},{"issue":"8","key":"10.1016\/j.neuropharm.2024.109897_bib135","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jaac.2011.05.001","article-title":"Genome-wide association study of the Child behavior checklist dysregulation profile","volume":"50","author":"Mick","year":"2011","journal-title":"J. Am. Acad. Child Adolesc. Psychiatr."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.109897_bib136","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1002\/ajmg.b.30865","article-title":"Genome-wide association study of response to methylphenidate in 187 children with attention-deficit\/hyperactivity disorder","volume":"147B","author":"Mick","year":"2008","journal-title":"Am. J. Med. Genet. Part B: Neuropsychiatric Genetics"},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109897_bib137","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1176\/appi.ajp.163.2.316","article-title":"Differences in brain chemistry in children and adolescents with attention deficit hyperactivity disorder with and without comorbid bipolar disorder: a proton magnetic resonance spectroscopy study","volume":"163","author":"Moore","year":"2006","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2024.109897_bib138","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1038\/s41598-021-81915-z","article-title":"Brain structural and functional substrates of ADGRL3 (latrophilin 3) haplotype in attention-deficit\/hyperactivity disorder","volume":"11","author":"Moreno-Alc\u00e1zar","year":"2021","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.109897_bib139","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1038\/s41380-022-01537-3","article-title":"Convergent selective signaling impairment exposes the pathogenicity of latrophilin-3 missense variants linked to inheritable ADHD susceptibility","volume":"27","author":"Moreno-Salinas","year":"2022","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2024.109897_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.02.039","article-title":"Dissociation of impulsivity and aggression in mice deficient for the ADHD risk gene Adgrl3: evidence for dopamine transporter dysregulation","volume":"156","author":"Mortimer","year":"2019","journal-title":"Neuropharmacology"},{"issue":"9","key":"10.1016\/j.neuropharm.2024.109897_bib141","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00702-023-02610-z","article-title":"Hemispheric asymmetries in mental disorders: evidence from rodent studies","volume":"130","author":"Mundorf","year":"2023","journal-title":"J. Neural. Transm."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109897_bib142","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.273","article-title":"Glutamatergic and GABAergic gene sets in attention-deficit\/hyperactivity disorder: association to overlapping traits in ADHD and autism","volume":"7","author":"Naaijen","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2024.109897_bib143","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.679960","article-title":"The role of parvalbumin interneurons in neurotransmitter balance and neurological disease","volume":"12","author":"Nahar","year":"2021","journal-title":"Front. Psychiatr."},{"issue":"9","key":"10.1016\/j.neuropharm.2024.109897_bib144","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.jaac.2010.06.008","article-title":"Meta-analysis of genome-wide association studies of attention deficit\/hyperactivity disorder","volume":"49","author":"Neale","year":"2010","journal-title":"J. Am. Acad. Child Adolesc. Psychiatr."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.109897_bib145","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1002\/ajmg.b.30866","article-title":"Genome-wide association scan of attention deficit hyperactivity disorder","volume":"147B","author":"Neale","year":"2008","journal-title":"Am. J. Med. Genet. Part B, Neuropsychiatric Genetics"},{"key":"10.1016\/j.neuropharm.2024.109897_bib146","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1146\/annurev.pharmtox.011008.145533","article-title":"Metabotropic glutamate receptors: physiology, pharmacology, and disease","volume":"50","author":"Niswender","year":"2010","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"10","key":"10.1016\/j.neuropharm.2024.109897_bib147","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3390\/brainsci9100288","article-title":"Integrated analysis of microRNA and mRNA expression profiles: an attempt to disentangle the complex interaction network in attention deficit hyperactivity disorder","volume":"9","author":"Nuzziello","year":"2019","journal-title":"Brain Sci."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.109897_bib148","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/aur.88","article-title":"Decreased GABAA receptors and benzodiazepine binding sites in the anterior cingulate cortex in autism","volume":"2","author":"Oblak","year":"2009","journal-title":"Autism Res. : Off. J. Int. Soc. Autism Res."},{"key":"10.1016\/j.neuropharm.2024.109897_bib149","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cortex.2020.01.006","article-title":"A graph theory study of resting-state functional connectivity in children with Tourette syndrome","volume":"126","author":"Openneer","year":"2020","journal-title":"Cortex"},{"issue":"3","key":"10.1016\/j.neuropharm.2024.109897_bib150","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1002\/mgg3.207","article-title":"Behavioral and transcriptomic profiling of mice null for Lphn3, a gene implicated in ADHD and addiction","volume":"4","author":"Orsini","year":"2016","journal-title":"Molecular Genetics & Genomic Medicine"},{"issue":"8","key":"10.1016\/j.neuropharm.2024.109897_bib151","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/npp.2011.51","article-title":"Schizophrenia-like attentional deficits following blockade of prefrontal cortex GABAA receptors","volume":"36","author":"Paine","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"10.1016\/j.neuropharm.2024.109897_bib152","doi-asserted-by":"crossref","first-page":"14977","DOI":"10.1096\/fj.202001544R","article-title":"N-linked glycosylation of the mGlu7 receptor regulates the forward trafficking and transsynaptic interaction with Elfn1","volume":"34","author":"Park","year":"2020","journal-title":"Faseb. J."},{"key":"10.1016\/j.neuropharm.2024.109897_bib153","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1744-9081-9-1","article-title":"Association between the GRM7 rs3792452 polymorphism and attention deficit hyperacitiveity disorder in a Korean sample","volume":"9","author":"Park","year":"2013","journal-title":"Behav. Brain Funct. : BBF"},{"issue":"8","key":"10.1016\/j.neuropharm.2024.109897_bib154","first-page":"743","article-title":"The modulation of neural noise underlies the effectiveness of methylphenidate treatment in attention-deficit\/hyperactivity disorder. Biological psychiatry","volume":"4","author":"Pertermann","year":"2019","journal-title":"Cognitive Neurosci. Neuroimag."},{"issue":"23","key":"10.1016\/j.neuropharm.2024.109897_bib155","doi-asserted-by":"crossref","first-page":"7931","DOI":"10.1523\/JNEUROSCI.3450-13.2014","article-title":"Too little and too much: hypoactivation and disinhibition of medial prefrontal cortex cause attentional deficits","volume":"34","author":"Pezze","year":"2014","journal-title":"J. Neurosci."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109897_bib156","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110616","article-title":"An atlas of transcriptionally defined cell populations in the rat ventral tegmental area","volume":"39","author":"Phillips","year":"2022","journal-title":"Cell Rep."},{"issue":"10222","key":"10.1016\/j.neuropharm.2024.109897_bib158","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0140-6736(19)33004-1","article-title":"Attention-deficit hyperactivity disorder","volume":"395","author":"Posner","year":"2020","journal-title":"Lancet (London, England)"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.109897_bib159","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005208","article-title":"A fragile balance: perturbation of GABA mediated circuit in prefrontal cortex generates high intraindividual performance variability","volume":"4","author":"Pouget","year":"2009","journal-title":"PLoS One"},{"issue":"6993","key":"10.1016\/j.neuropharm.2024.109897_bib160","doi-asserted-by":"crossref","DOI":"10.1038\/nature02615","article-title":"Routing of spike series by dynamic circuits in the hippocampus","volume":"429","author":"Pouille","year":"2004","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.neuropharm.2024.109897_bib161","doi-asserted-by":"crossref","first-page":"14082","DOI":"10.1073\/pnas.95.24.14082","article-title":"\u03922-Adrenergic receptor regulation by GIT1, a G protein-coupled receptor kinase-associated ADP ribosylation factor GTPase-activating protein","volume":"95","author":"Premont","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109897_bib162","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3325\/cmj.2023.64.110","article-title":"Cortical interneurons in schizophrenia \u2013 cause or effect?","volume":"64","author":"Prka\u010din","year":"2023","journal-title":"Croat. Med. J."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109897_bib163","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1152\/jn.00060.2015","article-title":"Reduced GABAergic inhibition and abnormal sensory symptoms in children with Tourette syndrome","volume":"114","author":"Puts","year":"2015","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2024.109897_bib164","doi-asserted-by":"crossref","DOI":"10.1016\/j.pscychresns.2020.111082","article-title":"Reduced striatal GABA in unmedicated children with ADHD at 7T","volume":"301","author":"Puts","year":"2020","journal-title":"Psychiatr. Res. Neuroimaging"},{"key":"10.1016\/j.neuropharm.2024.109897_bib166","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.neubiorev.2021.04.030","article-title":"Latrophilin-3 disruption: effects on brain and behavior","volume":"127","author":"Regan","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109897_bib167","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1601-183X.2010.00649.x","article-title":"Contribution of LPHN3 to the genetic susceptibility to ADHD in adulthood: a replication study","volume":"10","author":"Ribas\u00e9s","year":"2011","journal-title":"Gene Brain Behav."},{"issue":"10","key":"10.1016\/j.neuropharm.2024.109897_bib168","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.152","article-title":"Cadherin-13, a risk gene for ADHD and comorbid disorders, impacts GABAergic function in hippocampus and cognition","volume":"5","author":"Rivero","year":"2015","journal-title":"Transl. Psychiatry"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.109897_bib169","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1177\/1087054713510349","article-title":"Are there executive dysfunction subtypes within ADHD?","volume":"21","author":"Roberts","year":"2017","journal-title":"J. Atten. Disord."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.109897_bib170","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1152\/jn.00388.2019","article-title":"EEG power spectral slope differs by ADHD status and stimulant medication exposure in early childhood","volume":"122","author":"Robertson","year":"2019","journal-title":"J. Neurophysiol."},{"issue":"4","key":"10.1016\/j.neuropharm.2024.109897_bib171","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.neuron.2015.03.063","article-title":"Biased mGlu5 positive allosteric modulators provide in vivo efficacy without potentiating mGlu5 modulation of NMDAR currents","volume":"86","author":"Rook","year":"2015","journal-title":"Neuron"},{"issue":"18","key":"10.1016\/j.neuropharm.2024.109897_bib172","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1523\/JNEUROSCI.4873-07.2008","article-title":"Embryonically expressed GABA and glutamate drive electrical activity regulating neurotransmitter specification","volume":"28","author":"Root","year":"2008","journal-title":"J. Neurosci."},{"issue":"6","key":"10.1016\/j.neuropharm.2024.109897_bib173","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1176\/ajp.156.6.891","article-title":"Hypofrontality in attention deficit hyperactivity disorder during higher-order motor control: a study with functional mri","volume":"156","author":"Rubia","year":"1999","journal-title":"Am. J. Psychiatr."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109897_bib174","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/dneu.20853","article-title":"Three groups of interneurons account for nearly 100% of neocortical GABAergic neurons","volume":"71","author":"Rudy","year":"2011","journal-title":"Dev. Neurobiol."},{"issue":"22","key":"10.1016\/j.neuropharm.2024.109897_bib175","doi-asserted-by":"crossref","first-page":"8734","DOI":"10.1523\/JNEUROSCI.21-22-08734.2001","article-title":"Increased seizure susceptibility in mice lacking metabotropic glutamate receptor 7","volume":"21","author":"Sansig","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.109897_bib176","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8723623","article-title":"The current status of somatostatin-interneurons in inhibitory control of brain function and plasticity","author":"Scheyltjens","year":"2016","journal-title":"Neural Plast."},{"issue":"9","key":"10.1016\/j.neuropharm.2024.109897_bib177","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1002\/hbm.23244","article-title":"Brain GABA levels across psychiatric disorders: a systematic literature review and meta\u2010analysis of 1H\u2010MRS studies","volume":"37","author":"Sch\u00fcr","year":"2016","journal-title":"Hum. Brain Mapp."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109897_bib178","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jaac.2013.11.005","article-title":"Efficacy and safety of atomoxetine in children and adolescents with attention-deficit\/hyperactivity disorder: results from a comprehensive meta-analysis and metaregression","volume":"53","author":"Schwartz","year":"2014","journal-title":"J. Am. Acad. Child Adolesc. Psychiatr."},{"issue":"10","key":"10.1016\/j.neuropharm.2024.109897_bib179","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.biopsych.2006.04.031","article-title":"Dorsolateral prefrontal and anterior cingulate cortex volumetric abnormalities in adults with attention-deficit\/hyperactivity disorder identified by magnetic resonance imaging","volume":"60","author":"Seidman","year":"2006","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2024.109897_bib180","doi-asserted-by":"crossref","first-page":"23","DOI":"10.12688\/f1000research.12155.1","article-title":"Inhibitory control of the excitatory\/inhibitory balance in psychiatric disorders","volume":"7","author":"Selten","year":"2018","journal-title":"F1000Research"},{"issue":"7","key":"10.1016\/j.neuropharm.2024.109897_bib181","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.neuropharm.2009.08.011","article-title":"Genetics of attention-deficit hyperactivity disorder (ADHD)","volume":"57","author":"Sharp","year":"2009","journal-title":"Neuropharmacology"},{"issue":"8","key":"10.1016\/j.neuropharm.2024.109897_bib182","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1001\/archgenpsychiatry.2009.103","article-title":"Development of cortical asymmetry in typically developing children and its disruption in attention-deficit\/hyperactivity disorder","volume":"66","author":"Shaw","year":"2009","journal-title":"Arch. Gen. Psychiatr."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109897_bib183","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1176\/appi.ajp.2021.21010032","article-title":"Variable patterns of remission from ADHD in the multimodal treatment study of ADHD","volume":"179","author":"Sibley","year":"2022","journal-title":"Am. J. Psychiatr."},{"issue":"5","key":"10.1016\/j.neuropharm.2024.109897_bib184","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.neuron.2007.02.012","article-title":"Disynaptic inhibition between neocortical pyramidal cells mediated by Martinotti cells","volume":"53","author":"Silberberg","year":"2007","journal-title":"Neuron"},{"issue":"4","key":"10.1016\/j.neuropharm.2024.109897_bib185","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.biopsych.2013.01.033","article-title":"Frontal lobe GABA levels during adolescence: associations with impulsivity and response inhibition","volume":"74","author":"Silveri","year":"2013","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2024.109897_bib186","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s11689-022-09447-9","article-title":"An electronic health record (EHR) phenotype algorithm to identify patients with attention deficit hyperactivity disorders (ADHD) and psychiatric comorbidities","volume":"14","author":"Slaby","year":"2022","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.neuropharm.2024.109897_bib187","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.nicl.2017.06.003","article-title":"Age-dependent, lasting effects of methylphenidate on the GABAergic system of ADHD patients","volume":"15","author":"Solleveld","year":"2017","journal-title":"Neuroimage : Clinical"},{"issue":"43","key":"10.1016\/j.neuropharm.2024.109897_bib188","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.1523\/JNEUROSCI.1461-22.2023","article-title":"Presynaptic kainate receptors onto somatostatin interneurons are recruited by activity throughout development and contribute to cortical sensory adaptation","volume":"43","author":"Stachniak","year":"2023","journal-title":"J. Neurosci."},{"issue":"39","key":"10.1016\/j.neuropharm.2024.109897_bib189","doi-asserted-by":"crossref","first-page":"8150","DOI":"10.1523\/JNEUROSCI.1021-21.2021","article-title":"Postmitotic Prox1 expression controls the final specification of cortical VIP interneuron subtypes","volume":"41","author":"Stachniak","year":"2021","journal-title":"J. Neurosci."},{"issue":"23","key":"10.1016\/j.neuropharm.2024.109897_bib190","doi-asserted-by":"crossref","first-page":"4461","DOI":"10.1523\/JNEUROSCI.2276-18.2019","article-title":"Elfn1-Induced constitutive activation of mGluR7 determines frequency-dependent recruitment of somatostatin interneurons","volume":"39","author":"Stachniak","year":"2019","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.109897_bib191","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41380-022-01844-9","article-title":"Mapping the cortico-striatal transcriptome in attention deficit hyperactivity disorder","volume":"28","author":"Sudre","year":"2023","journal-title":"Mol. Psychiatr."},{"issue":"7","key":"10.1016\/j.neuropharm.2024.109897_bib192","doi-asserted-by":"crossref","DOI":"10.1038\/nn.2559","article-title":"More GABA, less distraction: a neurochemical predictor of motor decision speed","volume":"13","author":"Sumner","year":"2010","journal-title":"Nat. Neurosci."},{"issue":"6106","key":"10.1016\/j.neuropharm.2024.109897_bib193","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1126\/science.1222482","article-title":"Elfn1 regulates target-specific release probability at CA1-interneuron synapses","volume":"338","author":"Sylwestrak","year":"2012","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109897_bib194","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms5501","article-title":"Elfn1 recruits presynaptic mGluR7 in trans and its loss results in seizures","volume":"5","author":"Tomioka","year":"2014","journal-title":"Nat. Commun."},{"issue":"7419","key":"10.1016\/j.neuropharm.2024.109897_bib195","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nature11466","article-title":"Dopaminergic neurons inhibit striatal output via non-canonical release of GABA","volume":"490","author":"Tritsch","year":"2012","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.neuropharm.2024.109897_bib196","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3390\/biology12091241","article-title":"Attention deficit-hyperactivity disorder (ADHD): from abnormal behavior to impairment in synaptic plasticity","volume":"12","author":"Ugarte","year":"2023","journal-title":"Biology"},{"key":"10.1016\/j.neuropharm.2024.109897_bib157","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.62123","article-title":"Dissociation of impulsive traits by subthalamic metabotropic glutamate receptor 4","volume":"11","author":"Piszczek","year":"2022","journal-title":"Elife"},{"key":"10.1016\/j.neuropharm.2024.109897_bib197","unstructured":"Vaccarino, F. & Vaccarino, Flora. (n.d.). Mispatterning and interneuron deficit in Tourette Syndrome Basal Ganglia Organoids. NIMH Data Repositories. https:\/\/doi.org\/10.15154\/1526508."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109897_bib198","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.molcel.2020.01.020","article-title":"Imprinted maternally expressed microRNAs antagonize paternally driven gene programs in neurons","volume":"78","author":"Whipple","year":"2020","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.neuropharm.2024.109897_bib200","doi-asserted-by":"crossref","DOI":"10.1038\/nm.2330","article-title":"GIT1 is associated with ADHD in humans and ADHD-like behaviors in mice","volume":"17","author":"Won","year":"2011","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.109897_bib201","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.1002\/hbm.23642","article-title":"GABA metabolism and its role in gamma\u2010band oscillatory activity during auditory processing: an MRS and EEG study","volume":"38","author":"Wyss","year":"2017","journal-title":"Hum. Brain Mapp."},{"issue":"677","key":"10.1016\/j.neuropharm.2024.109897_bib202","doi-asserted-by":"crossref","first-page":"eabd2319","DOI":"10.1126\/scisignal.abd2319","article-title":"Input-specific regulation of glutamatergic synaptic transmission in the medial prefrontal cortex by mGlu2\/mGlu4 receptor heterodimers","volume":"14","author":"Xiang","year":"2021","journal-title":"Sci. Signal."},{"issue":"1","key":"10.1016\/j.neuropharm.2024.109897_bib203","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1523\/JNEUROSCI.1129-13.2014","article-title":"Selective actions of novel allosteric modulators reveal functional heteromers of metabotropic glutamate receptors in the CNS","volume":"34","author":"Yin","year":"2014","journal-title":"J. Neurosci."},{"issue":"46","key":"10.1016\/j.neuropharm.2024.109897_bib204","doi-asserted-by":"crossref","first-page":"11788","DOI":"10.1523\/JNEUROSCI.1970-16.2016","article-title":"Dorsolateral prefrontal cortex GABA concentration in humans predicts working memory load processing capacity","volume":"36","author":"Yoon","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.109897_bib206","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jpsychires.2020.09.035","article-title":"Association between the group III metabotropic glutamate receptor gene polymorphisms and attention-deficit\/hyperactivity disorder and functional exploration of risk loci","volume":"132","author":"Zhang","year":"2021","journal-title":"J. Psychiatr. Res."},{"issue":"8","key":"10.1016\/j.neuropharm.2024.109897_bib208","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1002\/ajmg.b.30878","article-title":"Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder","volume":"147B","author":"Zhou","year":"2008","journal-title":"Am. J. Med. Genet. Part B, Neuropsychiatric Genetics"},{"issue":"6","key":"10.1016\/j.neuropharm.2024.109897_bib209","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/npp.2008.131","article-title":"Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers","volume":"34","author":"Zhou","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/j.neuropharm.2024.109897_bib210","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.3390\/genes12091356","article-title":"A common CDH13 variant is associated with low agreeableness and neural responses to working memory tasks in ADHD","volume":"12","author":"Ziegler","year":"2021","journal-title":"Genes"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824000662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824000662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:28:40Z","timestamp":1758439720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390824000662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":204,"alternative-id":["S0028390824000662"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.109897","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel pharmacological targets for GABAergic dysfunction in ADHD","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.109897","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109897"}}